financetom
Business
financetom
/
Business
/
Texas Instruments Unusual Options Activity For April 04
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas Instruments Unusual Options Activity For April 04
Apr 4, 2024 12:57 PM

Whales with a lot of money to spend have taken a noticeably bullish stance on Texas Instruments ( TXN ).

Looking at options history for Texas Instruments ( TXN ) we detected 9 trades.

If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 44% with bearish.

From the overall spotted trades, 3 are puts, for a total amount of $349,010 and 6, calls, for a total amount of $195,091.

Predicted Price Range

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $165.0 to $180.0 for Texas Instruments ( TXN ) during the past quarter.

Volume & Open Interest Development

In today's trading context, the average open interest for options of Texas Instruments ( TXN ) stands at 1578.88, with a total volume reaching 1,734.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Texas Instruments ( TXN ), situated within the strike price corridor from $165.0 to $180.0, throughout the last 30 days.

Texas Instruments Call and Put Volume: 30-Day Overview

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
TXN PUT TRADE BULLISH 05/17/24 $4.4 $4.2 $4.15 $165.00 $249.0K 5.0K 710
TXN PUT SWEEP BEARISH 09/20/24 $10.55 $10.5 $10.55 $170.00 $73.8K 670 72
TXN CALL TRADE BULLISH 10/18/24 $12.7 $12.6 $12.7 $175.00 $44.4K 295 38
TXN CALL SWEEP BEARISH 04/12/24 $0.69 $0.66 $0.69 $177.50 $39.0K 195 581
TXN CALL TRADE BEARISH 09/20/24 $9.65 $9.6 $9.6 $180.00 $32.6K 961 51

About Texas Instruments

Dallas-based Texas Instruments ( TXN ) generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments ( TXN ) is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments ( TXN ) also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.

Having examined the options trading patterns of Texas Instruments ( TXN ), our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Current Position of Texas Instruments

With a trading volume of 3,333,527, the price of TXN is up by 1.11%, reaching $172.23.

Current RSI values indicate that the stock is is currently neutral between overbought and oversold.

Next earnings report is scheduled for 19 days from now.

What Analysts Are Saying About Texas Instruments

1 market experts have recently issued ratings for this stock, with a consensus target price of $170.0.

An analyst from Cantor Fitzgerald downgraded its action to Neutral with a price target of $170.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Texas Instruments ( TXN ), Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 11, 2024
July 11 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON STRENGTHENS PIPELINE TO LEAD IN ATOPIC DERMATITIS WITH THE COMPLETION OF THE ACQUISITION OF YELLOW JERSEY THERAPEUTICS, GAINING OWNERSHIP OF NM26 Source text for Eikon: Further company coverage: ...
GoGold Books Higher Q2 Silver Equivalent Production YoY at Parral Mine in Mexico
GoGold Books Higher Q2 Silver Equivalent Production YoY at Parral Mine in Mexico
Jul 11, 2024
08:15 AM EDT, 07/11/2024 (MT Newswires) -- GoGold Resources ( GLGDF ) reported on Thursday a second quarter year-on-year increase in silver equivalent production from the Parral tailings mine in Mexico. The company produced 400,236 ounces of silver equivalent, rising from 375,112 ounces. Gold production climbed to 2,436 ounces from 1,512 ounces and copper production was up to 148 tonnes...
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
Jul 11, 2024
July 11 (Reuters) - PepsiCo ( PEP ) missed expectations for second-quarter revenue on Thursday as a series of price hikes and competition from private-label brands slowed sales of its snacks and soda mainly in the United States, its largest market. Analysts have said that product prices, which are starting to normalize almost after two years of multiple hikes, are...
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Jul 11, 2024
08:16 AM EDT, 07/11/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that it has regained full rights to commercialize Vafseo tablets in the US after agreeing to terminate a license agreement with CSL Vifor. Akebia said it is now allowed to deal directly with all dialysis organizations effective immediately. Akebia said CSL Vifor is entitled to quarterly...
Copyright 2023-2026 - www.financetom.com All Rights Reserved